Clopidogrel might be better than aspirin for long-term heart disease

A comprehensive analysis of nearly 29,000 patients with coronary artery disease (CAD) suggests that clopidogrel, a commonly prescribed blood thinner, is more effective than aspirin in preventing serious heart and stroke events, without increasing the risk of major bleeding. The new study challenges the long-standing recommendation of aspirin as the default treatment for secondary prevention in CAD patients. CAD, a condition characterized by narrowed heart arteries, often requires lifelong treatment to prevent heart attacks, strokes, and cardiovascular death. Aspirin has traditionally been prescribed indefinitely for patients with CAD. However, the evidence supporting aspirin's long-term benefits and safety has been limited....